📰 Roche Diagnostics News
Page 69 - Roche Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roche Diagnostics. Real-time updates on events, politics, business and more.
January 28, 2022
/PRNewswire/ -- The "Insulin Pumps Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
January 28, 2022
/PRNewswire/ -- The "Insulin Pumps Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
January 28, 2022
The point of care diagnostics and testing market has climbed dramatically with the rise of the Covid-19 public health crisis. We're seeking applications for diagnostics startups who would like to take part in INVEST Pitch Perfect Diagnostics 2.0 track at the conference, scheduled to take place March 28-30 in Chicago.
January 27, 2022
Cervical cancer is one of the most common cancers affecting women worldwide. Low-income economies in Asia-Pacific should improve access to prevention and treatment to manage this preventable disease.
January 25, 2022
Shortages of both supplies and workers are wreaking havoc on the efforts of COVID-19 at-home test makers to deliver enough of the tests to Americans.
January 25, 2022
Fox News anchor Bill Hemmer Tuesday said he received his free COVID-19 tests through the mail under President Biden's new testing initiative, but noted the at-home kits were "made in China."
January 25, 2022
Viable cell density is commonly measured using automated cell counting devices, which rely on Trypan blue staining to identify living and dead cells. Algorithms automatically evaluate the generated images with stained and unstained cells. VCV can also be determined using these methods. AVC times viable cell density equals VCV, which is therefore a more comprehensive description of biomass. VCD alone is only a coarse measure.
January 25, 2022
Sen. Rick Scott, R-Fla., blasted the Biden administration for buying millions of coronavirus test kits that were made in China, saying taxpayer dollars should not be supporting "General Secretary Xi and his genocidal regime."
January 24, 2022
Shortages of both supplies and workers are wreaking havoc on the efforts of COVID-19 at-home test makers to deliver enough tests to Americans.
January 23, 2022
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Shortages of both supplies and workers are wreaking havoc on the efforts of COVID-19 at-home test makers to deliver enough of the tests to Americans, even as the federal government pledges to provide 500 million free, at-home kits. Like many other businesses, test kit manufacturers "have too many